Just a moment...
Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.
Step 1 – Issue Identification & Review
The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.
• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required
Step 2 – Draft Generation
Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.
• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review. 
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) whether the imported piperazine was a canalised drug falling within Appendix 9 of the Import Policy AM 1982-83 and therefore not importable under OGL; (ii) whether the redemption fine imposed on confiscation was excessive and required reduction.
Issue (i): Whether the imported piperazine was a canalised drug falling within Appendix 9 of the Import Policy AM 1982-83 and therefore not importable under OGL.
Analysis: The import was of piperazine, which the policy treated as a drug in Appendix 9. The fact that the sample did not conform to pharmaceutical grade specifications did not take it outside the category of drug, because sub-standard quality does not destroy the basic character of the substance as a drug. The policy did not confine canalisation only to standardised or pharmacopoeial grade material, and the item continued to be a basic drug notwithstanding its intended use as a drug intermediate.
Conclusion: The import was canalised and was not permissible under OGL; the confiscation under section 111(d) was upheld.
Issue (ii): Whether the redemption fine imposed on confiscation was excessive and required reduction.
Analysis: The goods were liable to confiscation, but the absence of any penalty under section 112, the industrial use of the importer, and the circumstances of import showed that the appellants were not acting with grave mala fides. The redemption fine at about 50% of the value was considered unduly high in the circumstances.
Conclusion: The redemption fine was reduced from Rs. 27,000 to Rs. 15,000.
Final Conclusion: The appeal failed on the challenge to confiscation, but partial relief was granted by reducing the redemption fine.
Ratio Decidendi: A substance does not cease to be a drug merely because it is not of pharmaceutical grade, if the policy treats the basic substance as a canalised drug; however, the quantum of redemption fine may be moderated on the facts of the case.